Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix
Authors:
- Y.T. KimYKY.T. Kim
- B.S. YoonBYB.S. Yoon
- J.W. KimJKJ.W. Kim
- S.H. KimS.H. Kim
- J.Y. KwonJKJ.Y. Kwon
- J.H. KimJ.H. Kim
- 25 July 2005
- journal article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 91 (1) , 47-52
Abstract
Objectives: To investigate whether pretreatment levels of serum squamous cell carcinoma antigen (SCCA) and urine polyamines can predict lymph node metastases in patients with early stage cervical carcinoma. Methods: Pretreatment measurement of serum SCCA and urine polyamine levels was carried out for 419 women. Of those women, 104 with stage IB and IIA cancer received radical surgery and had tumor size reassessed postoperatively. Results: The women had increased levels of serum SCCA (> 2.0 ng/mL) and elevated urine polyamines (> 45 μmol/g of creatinine) with advanced cancer stage (P < 0.01). The median SCCA level was significantly higher in women with metastatic disease than that in those without lymph node involvement (3.9 vs. 1.1; P < 0.01). Women with nodal involvement also had significantly higher median levels of urine polyamines than those without nodal disease. Conclusions: Pretreatment measurement of SCCA and urine polyamine levels may help in predicting lymph node metastases in women with early stage cervical carcinoma.Keywords
This publication has 20 references indexed in Scilit:
- Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervixCancer, 2003
- Can Initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis?Gynecologic Oncology, 2000
- The Value of Squamous Cell Carcinoma Antigen as a Predictor of Nodal Metastasis in Cervical CancerGynecologic Oncology, 1998
- Prognostic Significance of Pretreatment Squamous Cell Carcinoma Antigen and Carcinoembryonic Antigen in Squamous Cell Carcinoma of the Uterine CervixGynecologic Oncology, 1997
- Squamous Cell Carcinoma Antigen: Clinical Utility in Squamous Cell Carcinoma of the Uterine CervixGynecologic Oncology, 1994
- Squamous Cell Carcinoma Antigen, Tumor-Associated Trypsin Inhibitor, and Carcinoembryonic Antigen for Monitoring Cervical CancerAmerican Journal of Clinical Oncology, 1994
- Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinomaEuropean Journal of Cancer, 1992
- Revised FIGO staging for gynaecological cancerBJOG: An International Journal of Obstetrics & Gynaecology, 1989
- The influence of surgical staging on the evaluation and treatment of patients with cervical carcinomaGynecologic Oncology, 1986
- Results and complications of operative staging in cervical cancer: Experience of the Gynecologic Oncology GroupGynecologic Oncology, 1980